Future research implementing stimulation paradigms (Valstad et al., 2017) and/ or repeated sampling of plasma and/or salivary oxytocin (at baseline) (Martins et al., 2020) are required in order to sensitively and accurately characterise the physiology of the oxytocin system in craniopharyngioma. This evidence concerns the gene OXT and craniopharyngioma.